Definitions
Sorry, no definitions found. Check out and contribute to the discussion of this word!
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word zibotentan.
Examples
-
AstraZeneca lost another new drug from its pipeline with the discontinuation of zibotentan for prostate cancer, although hopes had not been very high for the medicine.
unknown title 2011
-
AstraZeneca lost another new drug from its pipeline with the discontinuation of zibotentan for prostate cancer, although hopes had not been very high for the medicine.
-
In February, it called off late-stage trials of a prostate cancer drug, zibotentan.
-
AstraZeneca suffers zibotentan drug setback AstraZeneca shares shrugged off another setback in the pharmaceuticals group's drugs programme, following the decision to halt advanced trials using zibotentan to treat a type of prostrate cancer.
Telegraph.co.uk - Telegraph online, Daily Telegraph and Sunday Telegraph 2011
-
The group has invested heavily in zibotentan over an eight-year period in the hope the treatment could slow tumour growth and the spread of cancer cells.
Telegraph.co.uk - Telegraph online, Daily Telegraph and Sunday Telegraph 2011
-
Trials are continuing to see whether zibotentan is more effective with chemotherapy in more advanced metastatic cancers with results expected in the second half of the year.
Telegraph.co.uk - Telegraph online, Daily Telegraph and Sunday Telegraph 2011
-
Five months ago AstraZeneca signalled that zibotentan was failing to show a significant improvement in the survival of patients with metastatic cancers which can spread to other parts of the body.
Telegraph.co.uk - Telegraph online, Daily Telegraph and Sunday Telegraph 2011
-
AstraZeneca Plc AZN LN: The drugmaker stopped a late- stage trial of the zibotentan treatment for a type of prostate cancer after a review showed the drug was unlikely to meet the goals of the study.
-
The drugmaker's experimental prostate cancer pill zibotentan failed to improve survival in a phase 3 clinical trial, prompting AstraZeneca (AZN) to hold off on a regulatory submission.
AstraZeneca Tries To Block Generic Rival - Investors.com 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.